A Study of BGM0504 in Participants With Obesity

Inclusion Criteria:

• ● Able and willing to provide a written informed consent.

• Male or female subjects, 18-65 years of age at the time of signing informedconsent.

• At screening visit, 35.0 ﹤BMI﹤ 45.0 kg/m2;

• Diet and exercise control for at least 3 months before screening visit, and beof stable weight (± 5%) self-reported change within the last 3 months.

Exclusion Criteria:

• ●History of chronic or acute pancreatitis.

• History of severe drug allergy or specific allergic disease or severeallergies.

• Family or personal history of medullary thyroid carcinoma (MTC) or multipleendocrine neoplasia syndrome type 2(MEN-2).

• History of malignant tumors [except carcinoma in situ with no recurrence within 5 years (except for malignant melanoma in situ), skin basal cell carcinoma andsquamous cell carcinoma].

• Suspected or confirmed history of alcohol or drug abuse;

• Any chronic infections likely to interfere with study conduct or interpretationsuch as hepatitis B (HBV), hepatitis C (HCV), human immunodeficiency virus (HIV) or treponema pallidum (TP).

• Donation or loss of 400 mL or more of blood within 3 months prior to screening,or blood donation during screening or within 3 months after the end of thetrial.

• Pregnant or lactating woman.

• Any disorder, unwillingness, or inability not covered by any of the otherexclusion criteria, which in the Investigator's opinion, might jeopardize theparticipant's safety or compliance with the protocol.